1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CEREVEL THERAPEUTICS HOLDINGS INC

Cerevel Therapeutics Holdings Inc

XNAS: CERE

Watchlist

Portfolio

Share


Insider Trading disclosures for Cerevel Therapeutics Holdings Inc

The latest disclosure was made by N. Anthony Coles in Cerevel Therapeutics Holdings Inc where a trade of 25,000 Stock Option (Right to Buy) done was reported to US exchanges on July 1, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2024 25,000 2,177,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 41.18 per share. 01 Jul 2024 25,000 25,928 - 41.2 1,029,535 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 01 Jul 2024 25,000 50,928 - 3.5 87,500 Common Stock
Deval L. Patrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 13,743 - - Common Stock
Douglas E. Giordano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 13,743 - - Common Stock
Gabrielle Sulzberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 58,876 - - Common Stock
N. Anthony Coles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,290 25,928 - - Common Stock
Norbert G. Riedel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 56,553 - - Common Stock
Marijn E. Dekkers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 42,283 - - Common Stock
Christopher Riley Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 13,743 - - Common Stock
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 13,743 - - Common Stock
Adam M. Koppel Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,461 13,743 - - Common Stock
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 40.61 per share. 03 Jun 2024 50,000 15,638 - 40.6 2,030,520 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 03 Jun 2024 50,000 65,638 - 3.5 175,000 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jun 2024 50,000 2,202,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2024 50,000 2,252,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 42.10 per share. 10 May 2024 50,000 15,638 - 42.1 2,105,125 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 10 May 2024 50,000 65,638 - 3.5 175,000 Common Stock
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 42.33 per share. 01 Apr 2024 50,000 15,638 - 42.3 2,116,640 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 01 Apr 2024 50,000 65,638 - 3.5 175,000 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2024 50,000 2,302,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2024 50,000 2,352,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 41.01 per share. 04 Mar 2024 50,000 15,638 - 41.0 2,050,550 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 04 Mar 2024 50,000 65,638 - 3.5 175,000 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 50,000 2,402,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 41.16 per share. 29 Feb 2024 50,000 15,638 - 41.2 2,057,890 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 29 Feb 2024 50,000 65,638 - 3.5 175,000 Common Stock
Anthony N. Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2024 15,440 46,322 - - Restricted Stock Units
Coles Anthony N. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2024 15,440 18,144 - - Common Stock
Renger John Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2024 5,020 8,531 - - Common Stock
Renger John Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2024 5,020 15,061 - - Restricted Stock Units
Renger John Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 41.54 per share. 06 Feb 2024 2,161 6,370 - 41.5 89,777 Common Stock
Anthony N. Coles Director Sale of securities on an exchange or to another person at price $ 41.54 per share. 06 Feb 2024 2,506 15,638 - 41.5 104,110 Common Stock
Altschuller Susan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 81,065 81,065 - - Restricted Stock Units
Renaud C. Ronald Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 284,023 284,023 - - Restricted Stock Units
Dipietro A. Kenneth Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 63,905 63,905 - - Restricted Stock Units
John Renger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 87,573 87,573 - - Restricted Stock Units
Akamine Scott Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 59,171 59,171 - - Restricted Stock Units
Bodenrader Mark See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 24,852 24,852 - - Restricted Stock Units
Kathleen Tregoning See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 59,171 59,171 - - Restricted Stock Units
Sanchez Raymond Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 87,573 87,573 - - Restricted Stock Units
Anthony N. Coles Director Sale of securities on an exchange or to another person at price $ 42.24 per share. 02 Jan 2024 50,000 2,704 - 42.2 2,111,815 Common Stock
N. Coles Anthony Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2024 50,000 2,452,417 - - Stock Option (Right to Buy)
Coles N. Anthony Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 02 Jan 2024 50,000 52,704 - 3.5 175,000 Common Stock
Gabrielle Sulzberger Director Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2023 562 48,415 - 0 Common Stock
Kathleen Tregoning See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.05 per share. 26 Dec 2023 3,150 10,666 - 10.1 31,658 Common Stock
Sanchez Raymond Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Dec 2023 10,000 538,435 - - Stock Option (Right to Buy)
Raymond Sanchez Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.47 per share. 26 Dec 2023 10,000 14,673 - 42.5 424,700 Common Stock
Sanchez Raymond Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 26 Dec 2023 10,000 24,673 - 3.5 35,000 Common Stock
Kathleen Tregoning See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Dec 2023 3,150 255,082 - - Stock Option (Right to Buy)
Dipietro Kenneth A. Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 41.45 per share. 22 Dec 2023 8,000 24,663 - 41.5 331,608 Common Stock
A. Kenneth Dipietro Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Dec 2023 8,000 302,242 - - Stock Option (Right to Buy)
A. Kenneth Dipietro Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 22 Dec 2023 8,000 32,663 - 3.5 28,000 Common Stock
Ronald C. Renaud Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 160,452 0 - - Restricted Stock Units
Dipietro Kenneth A. Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 13,913 0 - - Restricted Stock Units
Raymond Sanchez Chief Medical Officer Sale of securities on an exchange or to another person at price $ 41.42 per share. 19 Dec 2023 10,152 14,673 - 41.4 420,528 Common Stock
Mark Bodenrader See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 14,199 0 - - Restricted Stock Units
Renaud C. Ronald Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 160,452 160,452 - - Common Stock
Scott Akamine Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 13,796 14,309 - - Common Stock
Raymond Sanchez Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 24,825 0 - - Restricted Stock Units
Susan Altschuller Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 30,721 0 - - Restricted Stock Units
Dipietro A. Kenneth Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 41.42 per share. 19 Dec 2023 6,256 24,663 - 41.4 259,144 Common Stock
Susan Altschuller Chief Financial Officer Sale of securities on an exchange or to another person at price $ 41.42 per share. 19 Dec 2023 13,808 16,913 - 41.4 571,972 Common Stock
Mark Bodenrader See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 14,199 20,528 - - Common Stock
Raymond Sanchez Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 24,825 24,825 - - Common Stock
Susan Altschuller Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 30,721 30,721 - - Common Stock
Bodenrader Mark See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 5,085 25,613 - - Common Stock
A. Kenneth Dipietro Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 13,913 30,919 - - Common Stock
Tregoning Kathleen See Remarks Sale of securities on an exchange or to another person at price $ 41.42 per share. 19 Dec 2023 6,288 7,516 - 41.4 260,469 Common Stock
Mark Bodenrader See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 5,085 0 - - Restricted Stock Units
Scott Akamine Chief Legal Officer Sale of securities on an exchange or to another person at price $ 41.42 per share. 19 Dec 2023 7,072 7,237 - 41.4 292,945 Common Stock
Tregoning Kathleen See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 13,804 13,804 - - Common Stock
Bodenrader Mark See Remarks Sale of securities on an exchange or to another person at price $ 41.42 per share. 19 Dec 2023 7,889 17,724 - 41.4 326,788 Common Stock
Akamine Scott Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 13,796 0 - - Restricted Stock Units
Tregoning Kathleen See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2023 13,804 0 - - Restricted Stock Units
Raymond Sanchez Chief Medical Officer Sale of securities on an exchange or to another person at price $ 41.39 per share. 15 Dec 2023 7,500 0 - 41.4 310,393 Common Stock
Sanchez Raymond Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2023 7,500 123,390 - - Stock Option (Right to Buy)
Sanchez Raymond Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.88 per share. 15 Dec 2023 7,500 7,500 - 9.9 74,100 Common Stock
Raymond Sanchez Chief Medical Officer Sale of securities on an exchange or to another person at price $ 41.37 per share. 07 Dec 2023 10,000 0 - 41.4 413,700 Common Stock
Sanchez Raymond Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2023 10,000 548,435 - - Stock Option (Right to Buy)
Sanchez Raymond Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 07 Dec 2023 10,000 10,000 - 3.5 35,000 Common Stock
Scott Akamine Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 05 Dec 2023 10,000 10,513 - 13.2 131,700 Common Stock
Akamine Scott Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Dec 2023 10,000 254,262 - - Stock Option (Right to Buy)
Akamine Scott Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Dec 2023 7,500 264,262 - - Stock Option (Right to Buy)
Akamine Scott Chief Legal Officer Sale of securities on an exchange or to another person at price $ 35.00 per share. 05 Dec 2023 7,500 513 - 35 262,500 Common Stock
Scott Akamine Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 05 Dec 2023 7,500 8,013 - 13.2 98,775 Common Stock
Akamine Scott Chief Legal Officer Sale of securities on an exchange or to another person at price $ 41.37 per share. 05 Dec 2023 10,000 513 - 41.4 413,700 Common Stock
Ronald C. Renaud Director, President & CEO Purchase of securities on an exchange or from another person at price $ 23.96 per share. 03 Aug 2023 83,857 83,857 - 24.0 2,008,811 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jul 2023 50,000 2,702,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director Sale of securities on an exchange or to another person at price $ 30.03 per share. 11 Jul 2023 50,000 2,704 - 30.0 1,501,340 Common Stock
N. Anthony Coles Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 11 Jul 2023 50,000 52,704 - 3.5 175,000 Common Stock
Marijn E. Dekkers Director Sale of securities on an exchange or to another person at price $ 34.43 per share. 15 Jun 2023 200,000 402,326 - 34.4 6,886,000 Common Stock
Deval L. Patrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 3,282 - - Common Stock
Deval L. Patrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Douglas E. Giordano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Douglas E. Giordano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 3,282 - - Common Stock
Gabrielle Sulzberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Gabrielle Sulzberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 47,853 - - Common Stock
Norbert G. Riedel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 46,092 - - Common Stock
Norbert G. Riedel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Marijn E. Dekkers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 31,822 - - Common Stock
Marijn E. Dekkers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Christopher Riley Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 3,282 - - Common Stock
Christopher Riley Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Christopher Riley Gordon Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 07 Jun 2023 432,627 60,199,729 - 0 Common Stock
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 3,282 - - Common Stock
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
Adam M. Koppel Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 07 Jun 2023 432,627 60,199,729 - 0 Common Stock
Adam M. Koppel Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,282 3,282 - - Common Stock
Adam M. Koppel Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 13,780 13,780 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 32.60 per share. 01 Jun 2023 50,000 2,704 - 32.6 1,630,070 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2023 50,000 2,752,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 01 Jun 2023 50,000 52,704 - 3.5 175,000 Common Stock
Susan Altschuller Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 30,721 30,721 - - Restricted Stock Units
Susan Altschuller Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 124,168 124,168 - - Stock Option (Right to Buy)
Mark Bodenrader See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2023 4,733 7,417 - - Common Stock
Mark Bodenrader See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2023 4,733 14,199 - - Restricted Stock Units
Mark Bodenrader See Remarks Sale of securities on an exchange or to another person at price $ 32.95 per share. 01 Jun 2023 1,895 5,522 - 32.9 62,440 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 31.76 per share. 04 May 2023 12,132 3,004 - 31.8 385,287 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 04 May 2023 50,000 52,704 - 3.5 175,000 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 31.36 per share. 04 May 2023 37,568 15,136 - 31.4 1,178,268 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 32.93 per share. 04 May 2023 300 2,704 - 32.9 9,879 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2023 50,000 2,802,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 11 Apr 2023 50,000 52,704 - 3.5 175,000 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Apr 2023 50,000 2,852,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 25.06 per share. 11 Apr 2023 50,000 2,704 - 25.1 1,253,130 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 27.19 per share. 02 Mar 2023 3,000 2,704 - 27.2 81,570 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 02 Mar 2023 3,000 5,704 - 3.5 10,500 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 02 Mar 2023 47,000 49,704 - 3.5 164,500 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 27.11 per share. 02 Mar 2023 47,000 2,704 - 27.1 1,274,377 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2023 3,000 2,902,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2023 47,000 2,905,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 61,762 61,762 - - Restricted Stock Units
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 06 Feb 2023 50,000 52,704 - 3.5 175,000 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 33.04 per share. 06 Feb 2023 42,058 10,646 - 33.0 1,389,752 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 33.57 per share. 06 Feb 2023 7,942 2,704 - 33.6 266,649 Common Stock
N. Anthony Coles Director, CEO and Chairperson Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 243,042 243,042 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2023 50,000 2,952,417 - - Stock Option (Right to Buy)
Kenneth A. Dipietro Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 54,749 54,749 - - Stock Option (Right to Buy)
Kenneth A. Dipietro Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 13,913 13,913 - - Restricted Stock Units
Kathleen Tregoning See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 13,804 13,804 - - Restricted Stock Units
Kathleen Tregoning See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 54,320 54,320 - - Stock Option (Right to Buy)
Abraham Ceesay President Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 114,445 114,445 - - Stock Option (Right to Buy)
Abraham Ceesay President Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 29,083 29,083 - - Restricted Stock Units
Mark Bodenrader See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 20,012 20,012 - - Stock Option (Right to Buy)
Mark Bodenrader See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 5,085 5,085 - - Restricted Stock Units
John Renger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 20,081 20,081 - - Restricted Stock Units
John Renger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 79,022 79,022 - - Stock Option (Right to Buy)
Raymond Sanchez Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 24,825 24,825 - - Restricted Stock Units
Raymond Sanchez Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 97,691 97,691 - - Stock Option (Right to Buy)
Scott Akamine Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 13,796 13,796 - - Restricted Stock Units
Scott Akamine Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 54,292 54,292 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 29.93 per share. 05 Jan 2023 49,500 3,204 - 29.9 1,481,505 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 50,000 3,002,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 30.73 per share. 05 Jan 2023 500 2,704 - 30.7 15,366 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 05 Jan 2023 50,000 52,704 - 3.5 175,000 Common Stock
Gabrielle Sulzberger Director Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2022 49,624 14,270 - 0 Common Stock
Marijn E. Dekkers Director Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2022 14,270 28,540 - 0 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 09 Dec 2022 50,000 52,704 - 3.5 175,000 Common Stock
N. Anthony Coles Director, CEO and Chairperson Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2022 50,000 3,052,417 - - Stock Option (Right to Buy)
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 27.09 per share. 09 Dec 2022 5,145 2,704 - 27.1 139,395 Common Stock
N. Anthony Coles Director, CEO and Chairperson Sale of securities on an exchange or to another person at price $ 26.62 per share. 09 Dec 2022 44,855 7,849 - 26.6 1,193,906 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.28 per share. 01 Nov 2022 14,982 27,704 - 10.3 154,015 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2022 14,982 104,951 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2022 10,018 60,110 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 01 Nov 2022 25,000 2,704 - 30.0 750,005 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 01 Nov 2022 10,018 12,722 - 3.5 35,063 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.28 per share. 04 Oct 2022 14,982 27,704 - 10.3 154,015 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2022 14,982 119,933 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2022 10,018 70,128 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 04 Oct 2022 25,000 2,704 - 30 750,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 04 Oct 2022 10,018 12,722 - 3.5 35,063 Common Stock
Deval L. Patrick Director Sale of securities on an exchange or to another person at price $ 30.78 per share. 12 Sep 2022 47,705 0 - 30.8 1,468,422 Common Stock
Deval L. Patrick Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2022 47,705 42,685 - - Stock Option (Right to Buy)
Deval L. Patrick Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.62 per share. 12 Sep 2022 47,705 47,705 - 12.6 602,037 Common Stock
Abraham Ceesay President Sale of securities on an exchange or to another person at price $ 32.50 per share. 08 Sep 2022 19,210 0 - 32.5 624,325 Common Stock
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Sep 2022 19,210 365,009 - - Stock Option (Right to Buy)
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 08 Sep 2022 19,210 19,210 - 13.2 252,996 Common Stock
Abraham Ceesay President Sale of securities on an exchange or to another person at price $ 32.50 per share. 22 Aug 2022 9,605 0 - 32.5 312,163 Common Stock
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Aug 2022 9,605 384,219 - - Stock Option (Right to Buy)
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 22 Aug 2022 9,605 9,605 - 13.2 126,498 Common Stock
Abraham Ceesay President Sale of securities on an exchange or to another person at price $ 34.12 per share. 15 Aug 2022 9,606 0 - 34.1 327,757 Common Stock
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2022 9,606 393,824 - - Stock Option (Right to Buy)
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 15 Aug 2022 9,606 9,606 - 13.2 126,511 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.28 per share. 10 Aug 2022 25,376 57,704 - 10.3 260,865 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2022 25,376 134,915 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2022 29,624 80,146 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 41.10 per share. 10 Aug 2022 18,859 2,704 - 41.1 775,092 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 40.19 per share. 10 Aug 2022 36,141 21,563 - 40.2 1,452,532 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 10 Aug 2022 29,624 32,328 - 3.5 103,684 Common Stock
Scott Akamine Chief Legal Officer Sale of securities on an exchange or to another person at price $ 40.00 per share. 08 Aug 2022 10,000 0 - 40.0 400,001 Common Stock
Scott Akamine Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 08 Aug 2022 10,000 10,000 - 13.2 131,700 Common Stock
Scott Akamine Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Aug 2022 10,000 271,762 - - Stock Option (Right to Buy)
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 05 Aug 2022 38,424 38,424 - 13.2 506,044 Common Stock
Abraham Ceesay President Sale of securities on an exchange or to another person at price $ 39.50 per share. 05 Aug 2022 9,605 0 - 39.5 379,398 Common Stock
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 38,424 422,641 - - Stock Option (Right to Buy)
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 19,211 403,430 - - Stock Option (Right to Buy)
Abraham Ceesay President Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. 05 Aug 2022 19,211 19,211 - 13.2 253,009 Common Stock
Abraham Ceesay President Sale of securities on an exchange or to another person at price $ 32.50 per share. 05 Aug 2022 38,424 0 - 32.5 1,248,780 Common Stock
Abraham Ceesay President Sale of securities on an exchange or to another person at price $ 37.75 per share. 05 Aug 2022 9,606 9,605 - 37.8 362,627 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 05 Aug 2022 20,000 22,704 - 3.5 70,000 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 32.50 per share. 05 Aug 2022 20,000 2,704 - 32.5 650,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 05 Aug 2022 10,000 12,704 - 3.5 35,000 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 37.75 per share. 05 Aug 2022 10,000 2,704 - 37.8 377,500 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 20,000 119,770 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 10,000 109,770 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 20 Jul 2022 25,000 2,704 - 30 750,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jul 2022 25,000 139,770 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 20 Jul 2022 25,000 27,704 - 3.5 87,500 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 05 Jul 2022 25,000 2,704 - 30 750,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jul 2022 1,105 164,770 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jul 2022 25,000 165,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 32.50 per share. 05 Jul 2022 1,105 2,704 - 32.5 35,913 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 05 Jul 2022 1,105 3,809 - 3.5 3,868 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 05 Jul 2022 25,000 27,704 - 3.5 87,500 Common Stock
Gabrielle Sulzberger Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2022 14,270 63,894 - - Common Stock
Gabrielle Sulzberger Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2022 14,270 0 - - Restricted Stock Units
Deval L. Patrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Douglas E. Giordano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Gabrielle Sulzberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Norbert G. Riedel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Marijn E. Dekkers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Christopher Riley Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Adam M. Koppel Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 23,459 23,459 - - Stock Option (Right to Buy)
Mark Bodenrader See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 18,932 18,932 - - Restricted Stock Units
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 34.65 per share. 13 Apr 2022 45,000 1,980 - 34.6 1,559,093 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2022 45,000 190,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 13 Apr 2022 45,000 46,980 - 3.5 157,500 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 35.00 per share. 29 Mar 2022 10,000 1,980 - 35 350,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Mar 2022 10,000 235,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 29 Mar 2022 10,000 11,980 - 3.5 35,000 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 32.50 per share. 09 Mar 2022 20,000 11,980 - 32.5 650,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2022 30,000 290,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 35.00 per share. 09 Mar 2022 10,000 1,980 - 35 350,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 09 Mar 2022 30,000 31,980 - 3.5 105,000 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 02 Mar 2022 25,000 26,980 - 3.5 87,500 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2022 25,000 320,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 02 Mar 2022 25,000 1,980 - 30 750,000 Common Stock
Norbert G. Riedel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2022 14,270 42,810 - - Common Stock
Norbert G. Riedel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2022 14,270 0 - - Restricted Stock Units
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 23 Dec 2021 5,873 7,853 - 3.5 20,556 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2021 4,127 370,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2021 5,873 375,002 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 35.00 per share. 23 Dec 2021 4,127 1,980 - 35 144,445 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 23 Dec 2021 4,127 6,107 - 3.5 14,445 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 35.00 per share. 23 Dec 2021 5,873 1,980 - 35.0 205,582 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 32.50 per share. 21 Dec 2021 7,300 1,980 - 32.5 237,250 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 7,300 380,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 21 Dec 2021 7,300 9,280 - 3.5 25,550 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 38.59 per share. 10 Nov 2021 23,632 31,368 - 38.6 911,945 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2021 55,000 425,875 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 42.37 per share. 10 Nov 2021 2,063 0 - 42.4 87,419 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 41.44 per share. 10 Nov 2021 13,140 2,063 - 41.4 544,485 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 40.41 per share. 10 Nov 2021 10,030 15,203 - 40.4 405,335 Common Stock
John Renger Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 39.61 per share. 10 Nov 2021 6,135 25,233 - 39.6 243,004 Common Stock
John Renger Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 10 Nov 2021 55,000 55,000 - 3.5 192,500 Common Stock
Marijn E. Dekkers Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Sep 2021 14,270 0 - - Restricted Stock Units
Marijn E. Dekkers Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Sep 2021 14,270 42,810 - - Common Stock
Gabrielle Sulzberger Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2021 14,270 14,270 - - Restricted Stock Units
Gabrielle Sulzberger Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2021 14,270 49,624 - - Common Stock
Gabrielle Sulzberger Director Purchase of securities on an exchange or from another person at price $ 13.06 per share. 17 Jun 2021 21,084 35,354 - 13.1 275,357 Common Stock
Douglas E. Giordano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 58,003 58,003 - - Stock Option (Right to Buy)
Gabrielle Sulzberger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 58,003 58,003 - - Stock Option (Right to Buy)
Norbert G. Riedel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 58,003 58,003 - - Stock Option (Right to Buy)
Marijn E. Dekkers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 58,003 58,003 - - Stock Option (Right to Buy)
Christopher Riley Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 42,950 42,950 - - Stock Option (Right to Buy)
Adam M. Koppel Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 42,950 42,950 - - Stock Option (Right to Buy)
Abraham Ceesay President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2021 461,065 461,065 - - Stock Option (Right to Buy)
Scott Akamine Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2021 281,762 281,762 - - Stock Option (Right to Buy)
N. Anthony Coles Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 732,714 732,714 - - Stock Option (Right to Buy)
Kenneth A. Dipietro Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 175,438 175,438 - - Stock Option (Right to Buy)
Kathy Yi Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 216,718 216,718 - - Stock Option (Right to Buy)
Kathleen Tregoning See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 77,399 77,399 - - Stock Option (Right to Buy)
Mark Bodenrader See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 90,000 90,000 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 247,678 247,678 - - Stock Option (Right to Buy)
Raymond Sanchez Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 278,637 278,637 - - Stock Option (Right to Buy)
Deval L. Patrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 90,390 90,390 - - Stock Option (Right to Buy)
Deborah Baron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 90,390 90,390 - - Stock Option (Right to Buy)
Orly Mishan Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2021 38,450 426,913 - - Stock Option (Right to Buy)
Orly Mishan Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. 25 Jan 2021 38,450 38,450 - 3.5 134,575 Common Stock
Norbert G. Riedel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2021 14,270 14,270 - - Restricted Stock Units
Norbert G. Riedel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2021 14,270 28,540 - - Common Stock
Ruth Mckernan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 80,945 80,945 - - Stock Option (Right to Buy)
Kathleen Tregoning See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Dec 2020 78,229 78,229 - - Stock Option (Right to Buy)
Christopher R. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.30 per share. 09 Nov 2020 332,293 60,632,356 - 10.3 3,422,618 Common Stock
Adam M. Koppel Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.30 per share. 09 Nov 2020 332,293 60,632,356 - 10.3 3,422,618 Common Stock
N. Anthony Coles Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2020 196,335 196,335 - - Stock Option (Right to Buy)
Kathy Yi Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2020 78,534 78,534 - - Stock Option (Right to Buy)
Mark Bodenrader See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2020 65,445 65,445 - - Stock Option (Right to Buy)
John Renger Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2020 117,801 117,801 - - Stock Option (Right to Buy)
Raymond Sanchez Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2020 130,890 130,890 - - Stock Option (Right to Buy)
Christopher R. Gordon Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 27 Oct 2020 49,961,943 50,300,063 - - Common Stock
Christopher R. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.00 per share. 27 Oct 2020 10,000,000 60,300,063 - 10 100,000,000 Common Stock
Adam M. Koppel Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.00 per share. 27 Oct 2020 10,000,000 60,300,063 - 10 100,000,000 Common Stock
Adam M. Koppel Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 27 Oct 2020 49,961,943 50,300,063 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters